Transcriptional profiling experiments show that core components of the carnitine shuttle, CPT1, CPT2 and CACT are altered when TDP-43 proteinopathy is induced in motor neurons (see Figure 5 for model). This evidence concerns the gene CPT2 and proteostasis deficiencies.